The Galenica Group is taking over the physicians wholesaler Pharmapool Ltd. through its own pharmaceutical wholesale Company Galexis Ltd.
The company will continue to offer its services on the market under its current name and for management purposes will be integrated into Galenica Santé as part of the Services Business sector, which will be able to exploit attractive potential synergies in the future. Pharmapool has a staff of some 100 employees and records sales volume of over CHF 100 million.
Following expiry of the deadline for acceptance on 31 August 2016, 100% of the shareholders of Pharmapool Ltd. had accepted the purchase offer from Galexis. After the approval of the Competition Commission (COMCO) without any condition or requirement at the end of December 2016, the transaction was completed at the beginning of January 2017.
Kellerhals Carrard has advised Galexis AG on the deal with a team led by Beat Brechbühl (picture), assisted by Daniel Emch, Cécile Matter, Stefanie Schuler and Alexander Schütz.
Involved fees earner: Beat Brechbühl – Kellerhals Carrard; Alexander Schütz – Kellerhals Carrard; Cécile Matter – Kellerhals Carrard; Daniel Emch – Kellerhals Carrard; Stefanie Schuler – Kellerhals Carrard;
Law Firms: Kellerhals Carrard;
Clients: Galexis Ltd. ;